LEXINGTON, Mass., Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- Keros Therapeutics, Inc. ( &#34;Keros&#34; or the &#34;Company&#34; ) ( Nasdaq: KROS ) , today announced the preliminary results of its cash tender offer ( the &#34;Tender Offer&#34; ) to repurchase up to 10,950,165 shares of its common stock, at a fixed purchase ...

KROS

<p>馬薩諸塞州列剋星敦，2025 年 11 月 19 日（GLOBE NEWSWIRE）-- Keros Therapeutics, Inc.（“Keros” 或 “公司”）（納斯達克：KROS）今天宣佈了其現金收購要約（“收購要約”）的初步結果，計劃回購最多 10,950,165 股普通股，按固定價格</p>

Keros Therapeutics 宣佈要約收購的初步結果